Search for: "SANOFI INC." Results 81 - 100 of 436
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
IPO Webinar on Enablement and Written Description
27 Nov 2022, 8:10 pm by Patent Docs
Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Stephanie Donahue of Sanofi; Henry Hadad of Bristol-Meyers Squibb Co.; and Stuart Watt of Amgen, Inc. that will discuss the issues and arguments concerning the current state of enablement and written description law and where the law may be headed. [read post]
Patent Docs - http://www.patentdocs.org/
CAFC: PHOSITA Can Bridge Gaps with Reasonable Success Under Result-Effective Variable Doctrine
6 Mar 2024, 10:15 am by Steve Brachmann
Sanofi Pasteur Inc. affirming lower rulings by the Patent Trial and Appeal Board (PTAB) that invalidated Pfizer’s patent claims and denied motions to amend (MTA). [read post]
IPWatchdog - http://www.ipwatchdog.com/
CAFC: PHOSITA Can Bridge Gaps with Reasonable Success Under Result-Effective Variable Doctrine
6 Mar 2024, 10:15 am by Steve Brachmann
Sanofi Pasteur Inc. affirming lower rulings by the Patent Trial and Appeal Board (PTAB) that invalidated Pfizer’s patent claims and denied motions to amend (MTA). [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
3rd Cir. Rejects Attempt to Distinguish Campbell-Ewald, Holds Rule 68 Offer of Judgment Did Not Moot Claims
23 May 2016, 6:01 am by Thomas Dominczyk
Sanofi Pasteur, Inc. is […]Thomas Dominczyk [read post]
The Consumer Financial Services Blog - http://consumerfsblog.com/
Insights on Corporate Venture Capital
4 Mar 2015, 1:32 pm by Morse, Barnes-Brown Pendleton
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
MBBP's Good Company - http://blogmbbp.wordpress.com
Healthcare & Life Sciences Private Equity Deal Tracker: PE Firm Warburg Pincus Seeks to Sell Bausch & Lomb
8 Jan 2013, 11:23 am by Amber Walsh
Abbott Laboratories, Johnson & Johnson and Sanofi have reportedly shown interest in the company. [read post]
Health Care Investor - http://www.thehealthcareinvestor.com
Judge Robinson Issues Markman Opinion in Infringement Action Construing Six Disputed Terms in Patents-in-Suit
23 Oct 2015, 2:58 pm by Gregory B. Williams
Robinson in Amgen Inc. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Court Report
17 Jun 2007, 7:53 pm
Sanofi-Aventis U.S. [read post]
Patent Docs - http://www.patentdocs.org/
US Patent Office ARP Affirms the Use of Means-Plus-Function Limitations to Claim Antibodies
22 May 2024, 10:00 pm
Sanofi . [read post]
Well Done - https://www.morganlewis.com/blogs/welldone
US Patent Office ARP Affirms the Use of Means-Plus-Function Limitations to Claim Antibodies
22 May 2024, 10:00 pm
Sanofi . [read post]
Tech & Sourcing @ Morgan Lewis - https://www.morganlewis.com/blogs/sourcingatmorganlewis
US Patent Office ARP Affirms the Use of Means-Plus-Function Limitations to Claim Antibodies
22 May 2024, 10:00 pm
Sanofi . [read post]
As Prescribed - https://www.morganlewis.com/blogs/asprescribed
US Patent Office ARP Affirms the Use of Means-Plus-Function Limitations to Claim Antibodies
22 May 2024, 10:00 pm
Sanofi . [read post]
ML BeneBits - https://www.morganlewis.com/blogs/mlbenebits
US Patent Office ARP Affirms the Use of Means-Plus-Function Limitations to Claim Antibodies
22 May 2024, 10:00 pm
Sanofi . [read post]
Up & Atom - https://www.morganlewis.com/blogs/upandatom
US Patent Office ARP Affirms the Use of Means-Plus-Function Limitations to Claim Antibodies
22 May 2024, 10:00 pm
Sanofi . [read post]
Power & Pipes - https://www.morganlewis.com/blogs/powerandpipes
Sanofi prevails on PLAVIX at CAFC: enantiomer patentable over racemate
12 Dec 2008, 8:42 am
Apotex argues that the presumption should be particularly strong here, because the prior art patents belong to Sanofi. [read post]
IPBiz - http://ipbiz.blogspot.com/
Functional Claiming of Antibodies: (Continue to) Proceed With Caution
6 Oct 2017, 2:34 pm by Aaron Barkoff
Finding for Sanofi, the court held the sentence to be improper, relying heavily on its decision in Centocor Ortho Biotech, Inc. v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Functional Claiming of Antibodies: (Continue to) Proceed With Caution
6 Oct 2017, 2:34 pm by Aaron Barkoff
Finding for Sanofi, the court held the sentence to be improper, relying heavily on its decision in Centocor Ortho Biotech, Inc. v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Solicitor General Urges Supreme Court to Deny Cert in Amgen Antibody Patenting Case
26 Sep 2022, 6:39 am by Melissa Mitchell
” Gov’t CVSG Brief in Amgen Inc. v. [read post]
Filewrapper.com - https://www.filewrapper.com/
Rejoining Written Description and Enablement in Amgen v. Sanofi
9 Aug 2018, 5:16 pm by Dennis Crouch
”  Amgen Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
SCOTUS: “The More a Party Claims for Itself the More it Must Enable”
22 May 2023, 4:59 pm by Nathan Lee and Daniel Yannuzzi
Sanofi, et al., No. 21-757. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/